| Literature DB >> 32238166 |
Nele Carolin Heinemann1, Sabine Tischer-Zimmermann1,2, Torge Christian Wittke3, Julian Eigendorf3, Arno Kerling3, Theodor Framke4, Anette Melk5, Hans-Gert Heuft1,2, Rainer Blasczyk1,2, Britta Maecker-Kolhoff2,6, Britta Eiz-Vesper7,8.
Abstract
BACKGROUND: Adoptive transfer of virus-specific T cells (VSTs) represents a prophylactic and curative approach for opportunistic viral infections and reactivations after transplantation. However, inadequate frequencies of circulating memory VSTs in the T-cell donor's peripheral blood often result in insufficient enrichment efficiency and purity of the final T-cell product, limiting the effectiveness of this approach.Entities:
Keywords: Adoptive T-cell immunotherapy; High-intensity interval training; T-cell manufacturing; Virus-specific T cells
Mesh:
Year: 2020 PMID: 32238166 PMCID: PMC7114817 DOI: 10.1186/s12967-020-02301-3
Source DB: PubMed Journal: J Transl Med ISSN: 1479-5876 Impact factor: 5.531
Physical and fitness characteristics of the participants
| Characteristics | Group 1 (n = 6) | Group 2 (n = 6) | Total (n = 12) |
|---|---|---|---|
| Sex | 3 females, 3 males | 3 females, 3 males | 6 females, 6 male |
| Age (years) | 22.50 ± 2.07 | 25.67 ± 4.46 | 24.08 ± 3.70 |
| Height (cm) | 180.33 ± 10.41 | 175.17 ± 5.15 | 177.75 ± 8.28 |
| Mass (kg) | 77.78 ± 26.34 | 80.05 ± 13.31 | 78.92 ± 19.93 |
| BMI (kg/m2) | 23.44 ± 4.82 | 26.04 ± 4.09 | 24.73 ± 4.47 |
| Fitness level (IPAQ-score) | 4 moderate, 2 high | 4 moderate, 2 high | 8 moderate, 4 high |
| Individual performance limit (W) | 221.20 ± 36.27 | 236.50 ± 41.20 | 228.83 ± 37.90 |
| Individual performance limit (W/kg) | 2.97 ± 0.69 | 2.9 ± 0.50 | 2.93 ± 0.57 |
Each donor executed the two exercise protocols in crossover fashion. At the first visit (week 1), one group (n = 6, group 1) performed a single bout of continuous exercise (CONT) at 50% Pmax for 30 min, while the other group (n = 6, group 2) performed a single bout of high-intensity interval training (20 min of 30-s 100% Pmax intervals each followed by a 30-s pause 5 min before and after HIT exercises at 50% Pmax, more precisely High Intensity High Volume Training, HIHVT). At the second visit (week 3), each group switched over to the other exercise protocol. In other words, group 1 did continuous exercise during the first visit now and did HIT exercise on the second (CONT/HIT), and group 2 vice versa (HIT/CONT)
Fig. 1Exercise protocol and blood sampling. Heathy donors (n = 12) were separated into two groups and underwent two different training programs on two occasions separated by 14 days. In the first week group 1 (n = 6) completed a single bout of continuous exercise (CONT: 30 min at 50% of individual maximum capacity), whereas group 2 (n = 6) underwent a single bout of high-intensity interval training (HIT: 20 min of 30 s at maximum capacity followed by a 30 s pause, 5 min before and after HIT at 50% of individual maximum capacity). On the second visit exercise protocols were interchanged for both donor groups (week 3). Intravenous blood samples were collected before, directly, 1 h, and 24 h after exercise. The cellular immune status was determined directly in whole blood and specific T-cell responses were obtained in isolated peripheral blood mononuclear cells (PBMCs) using established immunoassays
Blood glucose, blood lactate, and heart rate in response to exercise
| Parameter | Program | Before exercise | During exercise | After exercise |
|---|---|---|---|---|
| Glucose (mmol/l) | CONT | 4.48 ± 0.40 | 4.15 ± 0.47 | 3.97 ± 0.41** |
| HIT | 5.12 ± 0.72 | 4.49 ± 0.50* | 4.35 ± 0.46* | |
| Lactate (mmol/l) | CONT | 1.00 ± 0.37 | 3.31 ± 1.21*** | 2.91 ± 1.61** |
| HIT | 0.97 ± 0.18 | 6.12 ± 1.98*** | 5.82 ± 2.54*** | |
| Heart rate (bpm) | CONT | 135.69 ± 15.00 | 153.07 ± 18.96* | 159.11 ± 17.75* |
| HIT | 138.66 ± 13.59 | 162.22 ± 14.61** | 165.40 ± 15.66** |
Glucose and lactate levels in peripheral blood and heart rate before, during and after exercise (CONT: continuous exercise, HIT: high-intensity interval training). Glucose and Lactate measured periodically, heart rate measured continuously. Asterisks indicate statistically significant differences between before, during and after exercise (*p < 0.05, **p < 0.01 and ***p < 0.001). Data are mean ± SD
Total and differential leukocyte counts, total red blood cell and platelet counts
| Parameter | Program | Before exercise | After exercise | 1 h after exercise | 24 h after exercise |
|---|---|---|---|---|---|
| Panel A | |||||
| Leukocytes (×103/µl] | CONT | 6.48 ± 1.38 | 7.59 ± 1.52 | 8.24 ± 1.50** | 7.02 ± 1.74 |
| HIT | 6.72 ± 1.19 | 7.51 ± 2.08 | 8.36 ± 2.32 | 6.87 ± 1.15 | |
| Lymphocytes (%) | CONT | 33.13 ± 8.10 | 31.97 ± 8.35 | 22.30 ± 6.58** | 28.86 ± 8.86 |
| HIT | 33.18 ± 8.40 | 30.14 ± 5.70 | 25.48 ± 6.84** | 31.37 ± 7.98 | |
| Monocytes (%) | CONT | 7.68 ± 8.1 | 7.59 ± 1.13 | 6.25 ± 1.42* | 6.97 ± 1.64 |
| HIT | 7.64 ± 1.74 | 7.57 ± 1.42 | 6.95 ± 1.03 | 7.58 ± 1.04 | |
| Granulocytes (%) | CONT | 59.18 ± 8.17 | 60.28 ± 8.55 | 71.45 ± 7.15** | 64.18 ± 9.43 |
| HIT | 59.18 ± 8.98 | 61.84 ± 5.32 | 67.55 ± 7.42* | 61.03 ± 8.62 | |
| Lymphocytes (×103/µl) | CONT | 2.06 ± 0.39 | 2.38 ± 0.50 | 1.80 ± 0.47 | 1.81 ± 0.66 |
| HIT | 2.18 ± 0.54 | 2.21 ± 0.61 | 2.07 ± 0.52 | 2.09 ± 0.51 | |
| Monocytes (×103/µl) | CONT | 0.53 ± 0.14 | 0.58 ± 0.10 | 0.52 ± 0.13 | 0.48 ± 0.11 |
| HIT | 0.52 ± 0.17 | 0.58 ± 0.20 | 0.59 ± 0.17 | 0.53 ± 0.11 | |
| Granulocytes (×103/µl) | CONT | 3.88 ± 1.19 | 4.64 ± 1.36 | 5.93 ± 1.46** | 4.63 ± 1.73 |
| HIT | 3.99 ± 1.02 | 4.73 ± 1.43 | 5.75 ± 1.92* | 4.17 ± 0.98 | |
| Red blood cell count (×106/µl) | CONT | 5.25 ± 0.94 | 5.30 ± 0.64 | 5.26 ± 0.99 | 5.299 ± 1.09 |
| HIT | 5.37 ± 0.64 | 5.44 ± 0.82 | 5.15 ± 0.91 | 5.028 ± 0.90 | |
| Hemoglobin [g/dl) | CONT | 15.36 ± 2.85 | 15.44 ± 1.97 | 15.32 ± 2.95 | 15.50 ± 3.24 |
| HIT | 15.69 ± 2.49 | 15.78 ± 2.30 | 14.96 ± 2.59 | 14.63 ± 2.55 | |
| Hematocrit [%) | CONT | 46.84 ± 8.41 | 47.00 ± 5.54 | 46.48 ± 8.49 | 46.92 ± 9.38 |
| HIT | 47.81 ± 6.43 | 47.99 ± 6.78 | 45.41 ± 7.69 | 44.43 ± 7.56 | |
| Platelet count (×103/µl) | CONT | 185.80 ± 67.21 | 213.20 ± 75.70 | 187.30 ± 72.87 | 176.30 ± 72.45 |
| HIT | 185.10 ± 48.55 | 203.40 ± 65.69 | 178.80 ± 53.26 | 186.80 ± 54.98 | |
| Plateletcrit (%) | CONT | 0.17 ± 0.05 | 0.19 ± 0.06 | 0.16 ± 0.06 | 0.15 ± 0.06 |
| HIT | 0.17 ± 0.05 | 0.18 ± 0.06 | 0.16 ± 0.05 | 0.16 ± 0.05 | |
Cell counts in peripheral blood (Panel A) analysed by using a haemocytometer as well as (Panel B) total leukocyte counts, total and proportional lymphocyte and T-cell counts analysed by flow cytometry before, directly after, 1 h after and 24 h after 30 min of continuous (CONT) and high-intensity interval (HIT) cycling exercise (n = 12). Statistically significant difference from before exercise indicated by (*p < 0.05 and **p < 0.01). Data are mean ± SD
Fig. 2Impact of a single continuous and interval exercise on antigen-specific T-cell responses. Peripheral blood samples of healthy donors (n = 12) were analysed at different time points before and after a single 30 min continuous (CONT) or interval (HIT) exercise (before, directly after, 1 h after and 24 h after exercise). Isolated PBMCs were stimulated overnight with a CMV-, b EBV- and c AdV-specific peptide pools (CMV pp65, CMV IE1, EBV EBNA1, EBV Consensus, AdV5 Hexon and AdV5 Penton) and frequencies of functional-active virus-specific T cells were determined by IFN-γ EliSpot assay. Negative and positive controls were carried out by using either medium without stimuli or 1 μg/ml staphylococcal enterotoxins B (SEB). Results are indicated as the number of spots per 2.5 × 105 cells/well (spw) and spots per 1000 CD3+ T cells, respectively after substracting the number of spw of the respective negative control. Positive controls showed a positive result for all analysed samples detected as TNTC (too numerous to count, TNTC ≥ 1000 spw). Results are displayed as mean ± SD. Asterisks indicate statistically significant differences between levels of induced cytokine responses (*p < 0.05)
Fig. 3Changes in frequencies of VSTs between moderately and highly fit donors. Donors were additionally classified into a moderately and a highly fit group according to the International Physical Activity Questionnaire (IPAQ). Frequencies of functional-active virus-specific T cells were determined by IFN-γ EliSpot assay. Negative and positive controls were carried out by using either medium or 1 μg/ml staphylococcal enterotoxins B (SEB). Results a in response to CMV, b EBV and c AdV from before and 24 h after exercise are shown as fold changes of spots per well per 1000 CD3+ T cells after subtracting those of the respective negative control. Positive control showed a positive result for all analysed samples detected as TNTC (too numerous to count, TNTC ≥ 1000 spw). Results are displayed as mean ± SD
Fig. 4Effects. of a single continuous and interval exercise on the activation capacity of functional IFN-γ+ antigen-specific T cells. Peripheral blood samples of healthy donors (n = 6) were analysed before, 1 h after and 24 h after a single 30 min interval (HIT) using IFN-γ Cytokine Secretion Assay (CSA). Isolated PBMCs were stimulated overnight with a CMV-, b EBV- and c AdV-specific peptide pools (CMV pp65, CMV IE1, EBV EBNA1, EBV Consensus, AdV5 Hexon and AdV5 Penton). Negative control was carried out by using unstimulated PBMCs. The relevant cell fractions before and after enrichment were used for a detailed flow cytometric analysis of IFN-γ+ T-cell subsets. Results are shown as fold changes of the frequency of CD3+/IFN-γ+, CD8+/IFN-γ+ and CD4+/IFN-γ+ cells after subtracting those of the respective negative control. CMV and AdV results are displayed as mean ± SD
Fig. 5Effects of a single continuous and interval exercise on CD8+ T-cell cholesterol and activation levels. Peripheral blood samples of healthy donors (n = 12) were analysed at different time points before and after exercise (before, directly after, 1 h after and 24 h after exercise), in which each donor at least completed one training program (CONT, 8/12 donors and HIT, 9/12 donors) to quantify the level of cholesterol and to analyse the CD69 expression on CD8+ T cells. Data are shown in total as mean ± SD. Statistically significant difference is indicated by (*p < 0.05) and (**p < 0.01). Cholesterol and cell activation related parameters were obtained as a Cholesterol (µM)/1 × 106 cells (Amplex Red Cholesterol Assay Kit) and b CD69 expression on CD8+ T cells (flow cytometry). c Additionally, the cholesterol level was analysed regarding the donors’ fitness level. 4/12 donors were classified as donors with a high fitness levels (CONT n = 3/4 and HIT n = 2/4) and 8/12 as donors with a moderate fitness level (CONT n = 5/8 and HIT n = 7/8)